+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user (Hospital, Surgical Centers & Medical Institutes), By Component (Software Solutions, Hardware and Services), By Cancer Type, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 86 Pages
  • November 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5709397
The Europe AI In Cancer Diagnostics Market should witness market growth of 28.0% CAGR during the forecast period (2022-2028).

AI technologies would be applied to crucial oncogenes. Early detection and treatment of cancer improve the chances of a cure. Some cancer cases, such as mouth, skin, testicles, breast, rectum, and prostate can be easily detected by the self-routine checkup and various screening measures before cancer becomes more dangerous and harmful.

Generally, most cancer cases are identified and discovered after the tumor can be perceptible or when other symptoms start appearing. Cancer can also be discovered by treating or examining other medical issues however these happen in a few cases. Cancer can be discovered through the reported testing of the urine, blood, and Stoll abnormalities which may sign of cancer case.

The cases of the neck postmortem are a standard check for the therapy of oral cavity cancer in the authorized head and neck cancer clinics established in Germany. 76% of instances of oral cavity cancer treated in certified centers will involve neck dissections. Head and neck cancers account for about 4% of all tumors in the US. Government spending on healthcare has upraised up to 4% annually in the United Kingdom. During the 1960s, the gross domestic product of healthcare products portraited less than 5% whereas after more than fifty years the GDP hiked up to 10%.

The Germany market dominated the Europe AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $33.8 million by 2028. The UK market is exhibiting a CAGR of 27% during (2022-2028). Additionally, The France market would experience a CAGR of 29% during (2022-2028).

Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.

Scope of the Study

By End-user

  • Hospital
  • Surgical Centers & Medical Institutes
  • Others

By Component

  • Software Solutions
  • Hardware
  • Services

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Brain Tumor
  • Skin Cancer & Cervical Cancer
  • Prostate & Colorectal Cancer
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Microsoft Corporation
  • Flatiron Health
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o.
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe AI In Cancer Diagnostics Market, by End-user
1.4.2 Europe AI In Cancer Diagnostics Market, by Component
1.4.3 Europe AI In Cancer Diagnostics Market, by Cancer Type
1.4.4 Europe AI In Cancer Diagnostics Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 The Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
Chapter 4. Europe AI In Cancer Diagnostics Market by End-user
4.1 Europe Hospital Market by Country
4.2 Europe Surgical Centers & Medical Institutes Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe AI In Cancer Diagnostics Market by Component
5.1 Europe Software Solutions Market by Country
5.2 Europe Hardware Market by Country
5.3 Europe Services Market by Country
Chapter 6. Europe AI In Cancer Diagnostics Market by Cancer Type
6.1 Europe Breast Cancer Market by Country
6.2 Europe Lung Cancer Market by Country
6.3 Europe Brain Tumor Market by Country
6.4 Europe Skin Cancer & Cervical Cancer Market by Country
6.5 Europe Prostate & Colorectal Cancer Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe AI In Cancer Diagnostics Market by Country
7.1 Germany AI In Cancer Diagnostics Market
7.1.1 Germany AI In Cancer Diagnostics Market by End-user
7.1.2 Germany AI In Cancer Diagnostics Market by Component
7.1.3 Germany AI In Cancer Diagnostics Market by Cancer Type
7.2 UK AI In Cancer Diagnostics Market
7.2.1 UK AI In Cancer Diagnostics Market by End-user
7.2.2 UK AI In Cancer Diagnostics Market by Component
7.2.3 UK AI In Cancer Diagnostics Market by Cancer Type
7.3 France AI In Cancer Diagnostics Market
7.3.1 France AI In Cancer Diagnostics Market by End-user
7.3.2 France AI In Cancer Diagnostics Market by Component
7.3.3 France AI In Cancer Diagnostics Market by Cancer Type
7.4 Russia AI In Cancer Diagnostics Market
7.4.1 Russia AI In Cancer Diagnostics Market by End-user
7.4.2 Russia AI In Cancer Diagnostics Market by Component
7.4.3 Russia AI In Cancer Diagnostics Market by Cancer Type
7.5 Spain AI In Cancer Diagnostics Market
7.5.1 Spain AI In Cancer Diagnostics Market by End-user
7.5.2 Spain AI In Cancer Diagnostics Market by Component
7.5.3 Spain AI In Cancer Diagnostics Market by Cancer Type
7.6 Italy AI In Cancer Diagnostics Market
7.6.1 Italy AI In Cancer Diagnostics Market by End-user
7.6.2 Italy AI In Cancer Diagnostics Market by Component
7.6.3 Italy AI In Cancer Diagnostics Market by Cancer Type
7.7 Rest of Europe AI In Cancer Diagnostics Market
7.7.1 Rest of Europe AI In Cancer Diagnostics Market by End-user
7.7.2 Rest of Europe AI In Cancer Diagnostics Market by Component
7.7.3 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent Strategies and Developments
8.2.5.1 Partnerships, Collaborations, and Agreements
8.3 Paige AI, Inc.
8.3.1 Company Overview
8.3.2 Recent Strategies and Developments
8.3.2.1 Partnerships, Collaborations, and Agreements
8.3.2.2 Product Launches and Product Expansions
8.4 PathAI, Inc.
8.4.1 Company Overview
8.4.2 Recent Strategies and Developments
8.4.2.1 Partnerships, Collaborations, and Agreements
8.4.2.2 Acquisition and Mergers
8.5 Therapixel
8.5.1 Company Overview
8.5.2 Recent Strategies and Developments
8.5.2.1 Product Launches and Product Expansions
8.6 Tempus, Inc.
8.6.1 Company Overview
8.6.2 Recent Strategies and Developments
8.6.2.1 Partnerships, Collaborations, and Agreements
8.7 SkinVision BV
8.7.1 Company Overview
8.8 Cancer Center Sp. z o.o.
8.8.1 Company Overview
8.9 Medial EarlySign
8.9.1 Company Overview
8.10. Kheiron Medical Technologies Limited
8.10.1 Company Overview
8.10.2 Recent Strategies and Developments
8.10.2.1 Partnerships, Collaborations, and Agreements

Companies Mentioned

  • Microsoft Corporation
  • Flatiron Health
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o.
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

Methodology

Loading
LOADING...